+ Filter
Loading...
Custom Services order now ship next day

Anti-TGFB Recombinant Antibody Products

Loading...

Anti-TGFB Products

View More Products

Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

More Infomation

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

For Research Use Only. Not For Clinical Use.


Creative Biolabs is at the forefront of developing high-quality anti-TGFβ recombinant antibody products, engineered to meet the diverse and stringent demands of global research and therapeutic development. Our comprehensive portfolio offers unparalleled specificity and efficacy, empowering scientists worldwide to accelerate breakthroughs in critical disease areas.

TGFB: a Versatile Target for Cancer Immunotherapy and Fibrotic Diseases

Transforming Growth Factor-β (TGF-β) is a pleiotropic cytokine with critical roles in cell proliferation, differentiation, apoptosis, and immune responses. While it can act as a tumor suppressor in early cancer stages, it often promotes tumor progression, metastasis, and drug resistance in advanced cancers by shaping the tumor microenvironment. Beyond oncology, dysregulated TGF-β signaling is a central driver of fibrogenesis across various organs, leading to excessive extracellular matrix accumulation and organ dysfunction. Understanding and modulating TGF-β pathways is therefore crucial for developing novel treatments for cancer and fibrotic disorders.

Alternative Names

Transforming growth factor beta; TGF-β; TGFbeta; TGFβ.

Background

This gene encodes a member of the transforming growth factor beta (TGFB) family of cytokines, which are multifunctional peptides that regulate proliferation, differentiation, adhesion, migration, and other functions in many cell types. Many cells have TGFB receptors, and the protein positively and negatively regulates many other growth factors. The secreted protein is cleaved into a latency-associated peptide (LAP) and a mature TGFB1 peptide, and is found in either a latent form composed of a TGFB1 homodimer, a LAP homodimer, and a latent TGFB1-binding protein, or in an active form composed of a TGFB1 homodimer. The mature peptide may also form heterodimers with other TGFB family members. This gene is frequently upregulated in tumor cells, and mutations in this gene result in Camurati-Engelmann disease.

Anti-TGFB rAb Products

Creative Biolabs offers a series of anti-TGFB recombinant antibodies that are meticulously engineered to deliver superior performance. These antibodies exhibit high affinity and specificity, thereby facilitating the precise targeting of TGFB isoforms. Leveraging advanced recombinant technology, our antibody production ensures exceptional batch-to-batch consistency and purity, attributes that are indispensable for obtaining reliable and reproducible experimental outcomes and for their potential utility in clinical applications.

Table 1. Featured anti-TGFB recombinant antibody products at Creative Biolabs.

Cat. No. Product Name Target Species Host Species Applications
HPAB-0019-YC Human Anti-TGFB Recombinant Antibody (HPAB-0019-YC) Human, Mouse Human IgG Neut
HPAB-0020-YC Human Anti-TGFB Recombinant Antibody (HPAB-0020-YC) Human Human IgG4 Neut
HPAB-0019-YC-S(P) Human Anti-TGFB Recombinant Antibody; scFv Fragment (HPAB-0019-YC-S(P)) Human, Mouse Human scFv Neut
HPAB-0020-YC-S(P) Human Anti-TGFB Recombinant Antibody; scFv Fragment (HPAB-0020-YC-S(P)) Human Human scFv Neut
HPAB-0019-YC-F(E) Human Anti-TGFB Recombinant Antibody; Fab Fragment (HPAB-0019-YC-F(E)) Human, Mouse Human Fab Neut

Creative Quality Control

At Creative Biolabs, we rigorously adhere to quality control protocols when performing production. The anti-TGFB recombinant antibodies produced by our facility are subjected to comprehensive, multi-faceted analytical procedures, encompassing techniques such as ELISA, flow cytometry, and bioactivity assays, thereby ensuring their optimal performance. Furthermore, each production lot undergoes meticulous validation for purity, specificity, and functional activity, which collectively guarantees the provision of consistent, high-quality reagents essential for diverse research and development applications.

Customer Reviews

Excellent
Am***a
Human Anti-TGFB Recombinant Antibody (HPAB-0020-YC) (CAT#: HPAB-0020-YC)
The anti-TGFB recombinant antibody from Creative Biolabs has significantly advanced our cancer immunotherapy research. Its consistent performance and high specificity have provided reliable data, accelerating our understanding of TGFB’s role in the tumor microenvironment.
18/Jul/2024
Excellent
Le***s
Mouse Anti-TGFB Recombinant Antibody (clone YC140) (MOB-086LC)
Using Creative Biolabs' anti-TGFB antibody in our fibrosis models has been a game-changer. The antibody's exceptional purity and activity allowed us to achieve clear, reproducible results, which were crucial for our mechanistic studies. It's a top-tier product that truly delivers on its promises for challenging applications.
11/Nov/2024
Excellent
Ja***n
Human Anti-TGFB Recombinant Antibody (HPAB-0019-YC) (CAT#: HPAB-0019-YC)
We've integrated Creative Biolabs' anti-TGFB recombinant antibody into our drug screening platform, and the results have been outstanding. Its robust performance across various assays, from binding studies to cell-based functional tests, has streamlined our workflow and enhanced the reliability of our therapeutic candidate identification.
22/Feb/2025

rAb Production

Our anti-TGFB recombinant antibodies are produced using state-of-the-art recombinant technology and mammalian expression systems, ensuring native folding and post-translational modifications for optimal biological activity. This robust production platform allows for scalable manufacturing while maintaining stringent quality standards, delivering a consistent supply of high-performance antibodies for diverse research needs.

Featured Anti-TGFB Recombinant Antibody Production PlatformsFig.1 Milligram-scale. (Creative Biolabs Original)
Fig.1 Milligram-scale anti-TGFB recombinant antibody production.

Fig.2 Gram-scale. (Creative Biolabs Original)Fig.2 Gram-scale anti-TGFB recombinant antibody production.

rAb Modalities

Creative Biolabs offers anti-TGFB recombinant antibodies in multiple modalities, including monoclonal, bispecific, engineered antibody fragments, and many others, providing versatile tools for various research and therapeutic strategies.

Fig.3 TGFB antibody production and modalities. (Creative Biolabs Original)Fig.3 Full-length anti-TGFB recombinant antibody production and modalities.

TGFB-Targeted Drug Information

Table 2. Public drug targeting TGFB.

Company Research phase Classification Condition
Acceleron Pharma (Merck & Co)
Celgene
Massachusetts General Hospital
M.D. Anderson Cancer Center (MD Anderson Cancer Center)
Merck & Co (Originator)
Launched - 2024 Fc Fusion Proteins
Polypeptides, from 41 AA
Anemia, chemotherapy-induced
Anemia in chronic kidney disease
Bone disorders
Cancer
Diamond-Blackfan anemia
End-stage renal disease
Eye Disorders
Hypertension, pulmonary arterial
Multiple myeloma
Myeloproliferative diseases
Osteoporosis
Osteoporosis, postmenopausal
Thalassemia, beta
Acceleron Pharma (Merck & Co)
Bristol-Myers Squibb
Celgene
Merck & Co (Originator)
Launched - 2019 Fc Fusion Proteins
Polypeptides, from 41 AA
Anemia
Eye Disorders
Myelodysplasia
Myelofibrosis
Thalassemia, alpha
Thalassemia, beta
Curative (Originator) Phase III Growth Factors
Multi-Component Products
Polypeptides, from 41 AA
Lesion, skin
HCW Biologics (Originator) Phase II Fusion Proteins
Polypeptides, from 41 AA
Cancer
Cancer, breast
Cancer, colorectal
Cancer, ovary
Cancer, pancreas
Cancer, prostate
Cancer, solid tumor
Diabetes type 2
Melanoma
Agenus (Originator)
Gilead
Phase II Cancer Immunotherapy
Fusion Proteins
Humanized Monoclonal Antibodies
Immunoconjugates
Polypeptides, from 41 AA
Cancer
Cancer, colorectal
Cancer, pancreas (ductal adenocarcinoma)
Cancer, solid tumor
EMD Serono
GlaxoSmithKline (GSK)
Merck KGaA (Originator)
National Cancer Institute (NCI) (National Cancer Institute)
Phase II Cancer Immunotherapy
Fusion Proteins
Immunoconjugates
Polypeptides, from 41 AA
Transforming Growth Factor-beta (TGF-beta)
Cancer
Cancer, bile duct
Cancer, biliary
Cancer, cervix
Cancer, colon (adenocarcinoma)
Cancer, colorectal
Cancer, gallbladder
Cancer, head and neck
Cancer, hepatobiliary
Cancer, lung (non-small cell) (NSCLC)
Cancer, metastatic (to brain)
Cancer, ovary
Cancer, pancreas (adenocarcinoma)
Cancer, prostate
Cancer, prostate (adenocarcinoma), metastatic
Cancer, rectum (adenocarcinoma)
Cancer, small intestine
Cancer, solid tumor
Cancer, stomach
Cholangiocarcinoma
Female reproductive system cancer
Genitourinary cancer
Glioblastoma multiforme
Mesothelioma, malignant
Neuroblastoma
Sarcoma
Triple negative breast cancer
Lilly (Originator) Phase II Monoclonal Antibodies Chronic kidney disease
Diabetic nephropathy
Astellas Pharma (Originator)
Novartis (Originator)
Oncogen
Universitair Medisch Centrum Groningen
Phase II Polypeptides, from 41 AA
Recombinant proteins
Transforming Growth Factor-beta (TGF-beta)
Cancer
Lesion, skin
Mucositis, chemotherapy- or radiotherapy-induced
Other dermatological disorders
Insmed (Originator)
Sanofi Genzyme
Phase II Polypeptides, from 41 AA
Recombinant proteins
Transforming Growth Factor-beta (TGF-beta)
Lesion, skin
Betta Pharmaceuticals (Originator) Phase I/II Bispecific Antibody Fusions
Cancer Immunotherapy
Fusion Proteins
Humanized Monoclonal Antibodies
Polypeptides, from 41 AA
Single-Domain Antibodies
Cancer, colorectal
Cancer, solid tumor
Suzhou Zelgen Biosciences (Originator) Phase I/II Bispecific Antibodies
Cancer Immunotherapy
Humanized Monoclonal Antibodies
Cancer, solid tumor
Transcenta (Originator) Phase I/II Cancer Immunotherapy
Humanized Monoclonal Antibodies
Cancer, prostate
Cancer, solid tumor

(Disclaimer: The information in this table is just for knowledge sharing and not for marketing or sales purposes.)

At Creative Biolabs, we are dedicated to supporting your scientific endeavors with cutting-edge solutions. Explore our comprehensive range of anti-TGFB recombinant antibody products today and discover how they can empower your next breakthrough. For detailed product information or to discuss your specific project requirements, please do not hesitate to get in touch with us.

Go to compare

Go to compare